The resolution of relapsing fever borreliosis requires IgM and is concurrent with expansion of B1b lymphocytes

被引:139
作者
Alugupalli, KR
Gerstein, RM
Chen, JZ
Szomolanyi-Tsuda, E
Woodland, RT
Leong, JM
机构
[1] Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA
[2] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA
[3] MIT, Ctr Canc Res, Cambridge, MA 02139 USA
关键词
D O I
10.4049/jimmunol.170.7.3819
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The rate of pathogen clearance is a critical determinant of morbidity and mortality. We sought to characterize the immune response responsible for the remarkably rapid clearance of individual episodes of bacteremia caused by the relapsing fever, bacterium, Borrelia hermsii. SCID or Rag(-/-) mice were incapable of resolving B. hermsii infection, indicating a critical role for T and/or B cells. TCR-/- mice, which lack T cells, and IL-7(-/-) mice, which are deficient in both T cells and follicular B cells, but not in B1 cells and splenic marginal zone (MZ) B cells, efficiently cleared B. hermsii. These findings suggested that B1 cells and/or MZ B cells, two B cell subsets that are known to participate in rapid, T-independent responses, might be involved. The efficient resolution of the episodes of moderate level bacteremia by splenectomized mice suggested that MZ B cells do not play the primary role in clearance of this bacterium. In contrast, xid mice, which are deficient in B1 cells, suffered more severe episodes of bacteremia than wild-type mice. The hypothesis that B1 cells are critical for clearance of B. hermsii was further supported by a selective expansion of the B1b (i.e., IgM(high), IgD(-/low), Mac1(+) CD23(-), and CD5(-)) cell subset in infected xid mice, which coincided with the eventual resolution of infection. Finally, mice selectively incapable of secreting IgM, the dominant isotype produced by B1 cells, were completely unable to clear B. hermsii. Together these results support the model that B1b cells generate the T-independent IgM required for the control and resolution of relapsing fever borreliosis.
引用
收藏
页码:3819 / 3827
页数:9
相关论文
共 48 条
  • [1] Serial determinations of platelet counts in mice by flow cytometry
    Alugupalli, KR
    Michelson, AD
    Barnard, MR
    Leong, JM
    [J]. THROMBOSIS AND HAEMOSTASIS, 2001, 86 (02) : 668 - 671
  • [2] Platelet activation by a relapsing fever spirochaete results in enhanced bacterium-platelet interaction via integrin αIIbβ3 activation
    Alugupalli, KR
    Michelson, AD
    Barnard, MR
    Robbins, D
    Coburn, J
    Baker, EK
    Ginsberg, MH
    Schwan, TG
    Leong, JM
    [J]. MOLECULAR MICROBIOLOGY, 2001, 39 (02) : 330 - 340
  • [3] CHARACTERIZATION OF PROTECTIVE ANTIBODIES PRODUCED IN MICE INFECTED WITH BORRELIA-DUTTONII
    ARIMITSU, Y
    AKAMA, K
    [J]. JAPANESE JOURNAL OF MEDICAL SCIENCE & BIOLOGY, 1973, 26 (5-6): : 229 - 237
  • [4] AVRAMEAS S, 1991, IMMUNOL TODAY, V12, P154
  • [5] Antigenic variation in vector-borne pathogens
    Barbour, AG
    Restrepo, BI
    [J]. EMERGING INFECTIOUS DISEASES, 2000, 6 (05) : 449 - 457
  • [6] ANTIGENIC VARIATION OF A RELAPSING FEVER BORRELIA SPECIES
    BARBOUR, AG
    [J]. ANNUAL REVIEW OF MICROBIOLOGY, 1990, 44 : 155 - 171
  • [7] In vitro and in vivo neutralization of the relapsing fever agent Borrelia hermsii with serotype-specific immunoglobulin M antibodies
    Barbour, AG
    Bundoc, V
    [J]. INFECTION AND IMMUNITY, 2001, 69 (02) : 1009 - 1015
  • [8] B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection
    Baumgarth, N
    Herman, OC
    Jager, GC
    Brown, LE
    Herzenberg, LA
    Chen, JZ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (02) : 271 - 280
  • [9] A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection
    Boes, M
    Prodeus, AP
    Schmidt, T
    Carroll, MC
    Chen, JZ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (12) : 2381 - 2386
  • [10] Boes M, 1998, J IMMUNOL, V160, P4776